SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-090262
Filing Date
2021-07-08
Accepted
2021-07-08 16:38:55
Documents
2
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121760-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121760-8_4seq1.xml 4 4001
2 EXHIBIT 24 tm2121760d8_ex24.htm EX-24 8173
  Complete submission text file 0001104659-21-090262.txt   13649
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Lubner David Charles (Reporting) CIK: 0001572000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39373 | Film No.: 211080619

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations